<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Soentjens,P.</style></author><author><style face="normal" font="default" size="100%">Andries,P.</style></author><author><style face="normal" font="default" size="100%">Damanet,B.</style></author><author><style face="normal" font="default" size="100%">Wauters,A.</style></author><author><style face="normal" font="default" size="100%">DeKoninck,K.</style></author><author><style face="normal" font="default" size="100%">Heuninckx,W.</style></author><author><style face="normal" font="default" size="100%">L. Remy</style></author><author><style face="normal" font="default" size="100%">Dooms,E.</style></author><author><style face="normal" font="default" size="100%">Steven Van Gucht</style></author><author><style face="normal" font="default" size="100%">De Crop,M.</style></author><author><style face="normal" font="default" size="100%">Ravinetto,R.</style></author><author><style face="normal" font="default" size="100%">Van Gompel,A.</style></author><author><style face="normal" font="default" size="100%">Aerssens,A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Initial neutralising antibody response on day 35 after two different intradermal rabies pre-exposure vaccination schedules: preliminary unpooled data of a large prospective clinical trial on rabies boostability</style></title><secondary-title><style face="normal" font="default" size="100%">http://dx.doi.org/10.1093/cid/cit080</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">a</style></keyword><keyword><style  face="normal" font="default" size="100%">antibodies</style></keyword><keyword><style  face="normal" font="default" size="100%">Antibody</style></keyword><keyword><style  face="normal" font="default" size="100%">Clinical</style></keyword><keyword><style  face="normal" font="default" size="100%">clinical trial</style></keyword><keyword><style  face="normal" font="default" size="100%">conference</style></keyword><keyword><style  face="normal" font="default" size="100%">data</style></keyword><keyword><style  face="normal" font="default" size="100%">International</style></keyword><keyword><style  face="normal" font="default" size="100%">intradermal</style></keyword><keyword><style  face="normal" font="default" size="100%">Medicine</style></keyword><keyword><style  face="normal" font="default" size="100%">ON</style></keyword><keyword><style  face="normal" font="default" size="100%">Rabies</style></keyword><keyword><style  face="normal" font="default" size="100%">response</style></keyword><keyword><style  face="normal" font="default" size="100%">Societies</style></keyword><keyword><style  face="normal" font="default" size="100%">Society</style></keyword><keyword><style  face="normal" font="default" size="100%">Travel</style></keyword><keyword><style  face="normal" font="default" size="100%">Vaccination</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">1/5/2013</style></date></pub-dates></dates><publisher><style face="normal" font="default" size="100%">NA</style></publisher><pub-location><style face="normal" font="default" size="100%">Maastricht</style></pub-location><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">CISTM</style></issue><custom1><style face="normal" font="default" size="100%">38351</style></custom1><custom2><style face="normal" font="default" size="100%">05/2013</style></custom2></record></records></xml>